Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Določanje mutacije V600E v genu BRAF
Authors:ID Škerl, Petra (Author)
ID Ličar, Alenka (Author)
ID Novaković, Srdjan (Author)
Files:.pdf PDF - Presentation file, download (272,73 KB)
MD5: F5974B7B95A6F8100F384F5A914E9E19
PID: 20.500.12556/dirros/ab56d3c2-9be9-4f5f-bfc2-5b9b4306b563
 
Language:Slovenian
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Mutacija V600E predstavlja več kot 90 % vseh opisanih mutacij v genu BRAF pri različnih vrstah tumorjev. Protein, ki nastane kot produkt onkogena BRAF z mutacijo V600E (BrafV600E), sproža nenehno signaliziranje prek signalne poti RAS-RAF-MAPK, kar povzroči številnejše delitve celice in njeno maligno transformacijo. Zato ima onkogen BrafV600E pomembno vlogo pri indukciji in napredovanju tumorja ter verjetno predstavlja zgodnji dogodek v procesu maligne transformacije. Po podatkih iz literature je čezmerno izražen v različnih vrstah solidnih tumorjev, kot so melanom, metastatski rak debelega črevesa in danke, papilarni rak ščitnice, rak ledvic (RCC), hepatocelularni karcinom (HCC), velikocelični rak pljuč (NSCLC) in serozni rak jajčnikov. Na Oddelku za molekularno diagnostiko smo uvedli metodo za določanje mutacije V600E v genu BRAF. Metoda temelji na PCR-pomnoževanju in uporabi specifičnih sond. Izkazala se je kot primerna za rutinsko diagnostiko. V primerjavi z neposrednim sekveniranjem, ki velja za zlati standard, sta bili njeni občutljivost in specifičnost 100-odstotni. Zaradi velike specifičnosti je zanesljiva za ločevanje med normalnim in mutiranim genotipom BRAF in je primerna za hitro rutinsko diagnostiko.
Publication status:Published
Publication version:Version of Record
Year of publishing:2010
Number of pages:str. 97-100, 167
Numbering:Letn. 14, št. 2
PID:20.500.12556/DiRROS-8851 New window
UDC:616-006.6-07
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-RPCTKJDT
COBISS.SI-ID:1045627 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:3487
Downloads:775
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:Detection of V600E Mutation in BRAF Gene
Abstract:The most common BRAF mutation, which accounts for more than 90% of all BRAF mutations described in different malignancies, is a glutamic acid for valin substitution at position 600 (V600E). BRAF gene carrying V600E mutation is termed BrafV600E oncogene. The product of BrafV600E is a protein which induces constitutive signaling in cells through hyperactivation of the RAS-RAF-MAPK pathway leading finally to increased cellular proliferation and malignant transformation. BrafV600E oncogene thus plays an important role in cancer induction and progression and is probably mutated early in the process of malignant transformation. According to the literature, BrafV600E oncogene is over-expressed in diverse human solid tumors: melanoma, colorectal carcinoma, papillary thyroid carcinoma, renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), non-small cell lung cancer (NSCLC) and serous ovarian cancer. At the Department of Molecular Diagnostics, we introduced a method for the detection of V600E mutation in BRAF gene based on real-time PCR and on application of specific probes. The method is robust and convenient for routine diagnostics. Its sensitivity and specificity when determined in comparison to the results of direct sequencing are as high as 100%. Due to the high specificity, the method allows the discrimination between normal and mutated BRAF genotypes and is therefore suitable for fast and accurate routine diagnostics.


Archive

niGradiv

Back